![Robert Lechleider](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Lechleider
Hoofd Techniek/Wetenschap/O&O bij
IMMUNOME, INC.
Vermogen: 2 M $ op 31-08-2026
Profiel
Robert Lechleider is currently Chief Medical Officer at Immunome, Inc. since 2023.
Formerly, Dr. Lechleider was Chief Medical Officer at OncoResponse, Inc. from 2020 to 2023 and Senior Vice President-Clinical Development at Seagen, Inc. from 2016 to 2020.
Education includes undergraduate studies at Princeton University and a doctorate from the University of Illinois College of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
IMMUNOME, INC. 0,06% | 23-07-2026 | 69.805 ( 0,06% ) | 2 M $ | 31-08-2026 |
Actieve functies van Robert Lechleider
| Bedrijven | Functie | Begin |
|---|---|---|
| IMMUNOME, INC. | Hoofd Techniek/Wetenschap/O&O | 19-10-2023 |
Eerdere bekende functies van Robert Lechleider
| Bedrijven | Functie | Einde |
|---|---|---|
OncoResponse, Inc.
 OncoResponse, Inc. Pharmaceuticals: MajorHealth Technology Discovers cancer immunotherapies by interrogating the human immune system | Hoofd Techniek/Wetenschap/O&O | 01-10-2023 |
| SEAGEN INC. | Hoofd Techniek/Wetenschap/O&O | 01-04-2020 |
Opleiding van Robert Lechleider
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
37
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cancer medicines | Health Technology |
Immunome, Inc.
 Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics | Health Technology |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois College of Medicine
 University of Illinois College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OncoResponse, Inc.
OncoResponse, Inc. Pharmaceuticals: MajorHealth Technology Discovers cancer immunotherapies by interrogating the human immune system | Health Technology |
